Oren Teague Mcnulty

Title: Oren Teague Mcnulty: Innovator in Protein Tyrosine Phosphatase Inhibitors

Introduction

Oren Teague Mcnulty is a notable inventor based in Nederland, Colorado, who has made significant contributions to the field of biopharmaceuticals. He holds two patents that focus on the development of protein tyrosine phosphatase inhibitors, which are crucial for treating hyperproliferative diseases. His work is instrumental in advancing medical treatments and improving patient outcomes.

Latest Patents

Oren Mcnulty's latest patents include innovative compounds of Formula Ia and Formula I, which are designed to act as protein tyrosine phosphatase inhibitors. These compounds, along with their stereoisomers, tautomers, prodrugs, or pharmaceutically acceptable salts, are useful for the treatment of hyperproliferative diseases. The patents also disclose methods for using these compounds in vitro, in situ, and in vivo for the diagnosis, prevention, or treatment of associated pathological conditions in mammalian cells.

Career Highlights

Oren Mcnulty is currently associated with Array Biopharma Inc., where he continues to work on groundbreaking research in the biopharmaceutical sector. His expertise in developing therapeutic compounds has positioned him as a key player in the industry. His contributions are vital for the advancement of treatments for various diseases.

Collaborations

Oren has collaborated with notable colleagues, including James F Blake and Mark Laurence Boys, who share his commitment to innovation in the field of biopharmaceuticals. Their combined efforts enhance the research and development of effective treatments.

Conclusion

Oren Teague Mcnulty is a distinguished inventor whose work in protein tyrosine phosphatase inhibitors is paving the way for new therapeutic options. His patents and collaborations reflect his dedication to improving healthcare through innovative solutions.